Integrated analysis of the association between methionine cycle and risk of moyamoya disease.
Junsheng LiQiheng HeChenglong LiuChao-Fan ZengChuming TaoYuanren ZhaiWei LiuQian ZhangRong WangYan ZhangPeicong GeDong ZhangJi-Zong ZhaoPublished in: CNS neuroscience & therapeutics (2023)
This study has constructed and validated a risk model based on Met cycle-related metabolites, which was independently associated with the risk of MMD and its subtypes. The findings provided a new perspective on the risk evaluation and prevention of MMD.
Keyphrases